1. Home
  2. SKYT vs KMDA Comparison

SKYT vs KMDA Comparison

Compare SKYT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYT
  • KMDA
  • Stock Information
  • Founded
  • SKYT 1991
  • KMDA 1990
  • Country
  • SKYT United States
  • KMDA Israel
  • Employees
  • SKYT N/A
  • KMDA N/A
  • Industry
  • SKYT Semiconductors
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYT Technology
  • KMDA Health Care
  • Exchange
  • SKYT Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • SKYT 462.3M
  • KMDA 442.1M
  • IPO Year
  • SKYT 2021
  • KMDA N/A
  • Fundamental
  • Price
  • SKYT $9.69
  • KMDA $7.46
  • Analyst Decision
  • SKYT Strong Buy
  • KMDA Strong Buy
  • Analyst Count
  • SKYT 4
  • KMDA 2
  • Target Price
  • SKYT $12.75
  • KMDA $14.50
  • AVG Volume (30 Days)
  • SKYT 577.0K
  • KMDA 346.0K
  • Earning Date
  • SKYT 02-26-2025
  • KMDA 03-05-2025
  • Dividend Yield
  • SKYT N/A
  • KMDA N/A
  • EPS Growth
  • SKYT N/A
  • KMDA 124.29
  • EPS
  • SKYT N/A
  • KMDA 0.27
  • Revenue
  • SKYT $345,935,000.00
  • KMDA $158,380,000.00
  • Revenue This Year
  • SKYT $21.36
  • KMDA $15.37
  • Revenue Next Year
  • SKYT N/A
  • KMDA $8.58
  • P/E Ratio
  • SKYT N/A
  • KMDA $28.13
  • Revenue Growth
  • SKYT 26.89
  • KMDA 4.52
  • 52 Week Low
  • SKYT $5.63
  • KMDA $4.74
  • 52 Week High
  • SKYT $19.00
  • KMDA $9.15
  • Technical
  • Relative Strength Index (RSI)
  • SKYT 50.02
  • KMDA 52.89
  • Support Level
  • SKYT $10.20
  • KMDA $7.51
  • Resistance Level
  • SKYT $10.97
  • KMDA $8.35
  • Average True Range (ATR)
  • SKYT 0.49
  • KMDA 0.41
  • MACD
  • SKYT 0.14
  • KMDA -0.02
  • Stochastic Oscillator
  • SKYT 72.93
  • KMDA 33.20

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: